syna-10q_20190928.htm
false 2020 Q1 SYNAPTICS Inc 0000817720 --06-27 Large Accelerated Filer true 0.3333 0.3333 0.3333 0.2500 2.00 P1Y7M6D 0.3333 P9M18D 2020 P5Y 0.3333 0.2500 P1Y P2Y P3Y P4Y 2.00 0.3333 P3Y 0.3333 0.3333 P5Y3M18D P5Y3M18D P4Y1M6D P4Y2M12D P8Y1M6D P7Y P4Y10M24D 0000817720 2019-06-29 2019-09-28 xbrli:shares 0000817720 2019-11-01 iso4217:USD 0000817720 2019-09-30 0000817720 2019-06-30 iso4217:USD xbrli:shares 0000817720 2019-07-01 2019-09-30 0000817720 2018-07-01 2018-09-30 0000817720 us-gaap:CommonStockMember 2019-06-30 0000817720 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000817720 us-gaap:TreasuryStockMember 2019-06-30 0000817720 us-gaap:RetainedEarningsMember 2019-06-30 0000817720 us-gaap:CommonStockMember srt:RestatementAdjustmentMember 2019-06-30 0000817720 us-gaap:AdditionalPaidInCapitalMember srt:RestatementAdjustmentMember 2019-06-30 0000817720 us-gaap:TreasuryStockMember srt:RestatementAdjustmentMember 2019-06-30 0000817720 us-gaap:RetainedEarningsMember srt:RestatementAdjustmentMember 2019-06-30 0000817720 srt:RestatementAdjustmentMember 2019-06-30 0000817720 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000817720 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0000817720 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000817720 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000817720 us-gaap:CommonStockMember 2019-09-30 0000817720 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000817720 us-gaap:TreasuryStockMember 2019-09-30 0000817720 us-gaap:RetainedEarningsMember 2019-09-30 0000817720 us-gaap:CommonStockMember 2018-06-30 0000817720 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000817720 us-gaap:TreasuryStockMember 2018-06-30 0000817720 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000817720 us-gaap:RetainedEarningsMember 2018-06-30 0000817720 2018-06-30 0000817720 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0000817720 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0000817720 us-gaap:CommonStockMember 2018-07-01 2018-09-30 0000817720 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0000817720 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0000817720 us-gaap:CommonStockMember 2018-09-30 0000817720 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000817720 us-gaap:TreasuryStockMember 2018-09-30 0000817720 us-gaap:RetainedEarningsMember 2018-09-30 0000817720 2018-09-30 0000817720 syna:DeferredStockUnitsMember 2019-07-01 2019-09-30 0000817720 syna:MarketStockUnitsMember 2019-07-01 2019-09-30 0000817720 syna:PerformanceStockUnitsMember 2019-07-01 2019-09-30 0000817720 us-gaap:SalesRevenueNetMember 2019-07-01 2019-09-30 0000817720 us-gaap:AccountsReceivableMember 2019-07-01 2019-09-30 0000817720 srt:MaximumMember 2019-07-01 2019-09-30 0000817720 us-gaap:AccountingStandardsUpdate201409Member 2019-09-30 0000817720 us-gaap:StockCompensationPlanMember 2019-07-01 2019-09-30 0000817720 us-gaap:StockCompensationPlanMember 2018-07-01 2018-09-30 0000817720 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2019-09-30 0000817720 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2019-06-30 0000817720 syna:DisplayDriverTechnologyMember 2019-09-30 0000817720 syna:AudioAndVideoTechnologyMember 2019-09-30 0000817720 us-gaap:CustomerRelationshipsMember 2019-09-30 0000817720 syna:LicensedTechnologyAndOtherMember 2019-09-30 0000817720 us-gaap:PatentsMember 2019-09-30 0000817720 us-gaap:TradeNamesMember 2019-09-30 0000817720 syna:DisplayDriverTechnologyMember 2019-06-30 0000817720 syna:AudioAndVideoTechnologyMember 2019-06-30 0000817720 us-gaap:CustomerRelationshipsMember 2019-06-30 0000817720 syna:FingerprintAuthenticationTechnologyMember 2019-06-30 0000817720 syna:LicensedTechnologyAndOtherMember 2019-06-30 0000817720 us-gaap:PatentsMember 2019-06-30 0000817720 us-gaap:TradeNamesMember 2019-06-30 0000817720 syna:DisplayDriverTechnologyMember 2019-07-01 2019-09-30 0000817720 syna:AudioAndVideoTechnologyMember 2019-07-01 2019-09-30 0000817720 us-gaap:CustomerRelationshipsMember 2019-07-01 2019-09-30 0000817720 syna:LicensedTechnologyAndOtherMember 2019-07-01 2019-09-30 0000817720 us-gaap:PatentsMember 2019-07-01 2019-09-30 0000817720 us-gaap:TradeNamesMember 2019-07-01 2019-09-30 0000817720 us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0000817720 us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0000817720 srt:MaximumMember 2019-09-30 xbrli:pure 0000817720 syna:ZeroPointFiveZeroPercentConvertibleSeniorNotesDueTwoThousandTwentyTwoMember 2019-09-30 0000817720 syna:ZeroPointFiveZeroPercentConvertibleSeniorNotesDueTwoThousandTwentyTwoMember 2019-07-01 2019-09-30 syna:Day 0000817720 us-gaap:RevolvingCreditFacilityMember syna:AmendmentAndRestatementAgreementMember 2017-09-30 0000817720 us-gaap:LetterOfCreditMember syna:AmendmentAndRestatementAgreementMember 2017-09-30 0000817720 us-gaap:BridgeLoanMember syna:AmendmentAndRestatementAgreementMember 2017-09-30 0000817720 us-gaap:RevolvingCreditFacilityMember syna:AmendmentAndRestatementAgreementMember 2019-09-30 0000817720 syna:AmendmentAndRestatementAgreementMember us-gaap:RevolvingCreditFacilityMember 2019-07-01 2019-09-30 0000817720 us-gaap:RevolvingCreditFacilityMember syna:AmendmentAndRestatementAgreementMember us-gaap:FederalFundsEffectiveSwapRateMember 2019-07-01 2019-09-30 0000817720 us-gaap:RevolvingCreditFacilityMember syna:AmendmentAndRestatementAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember 2019-07-01 2019-09-30 0000817720 us-gaap:RevolvingCreditFacilityMember syna:AmendmentAndRestatementAgreementMember us-gaap:BaseRateMember srt:MinimumMember 2019-07-01 2019-09-30 0000817720 us-gaap:RevolvingCreditFacilityMember syna:AmendmentAndRestatementAgreementMember us-gaap:BaseRateMember srt:MaximumMember 2019-07-01 2019-09-30 0000817720 us-gaap:RevolvingCreditFacilityMember syna:AmendmentAndRestatementAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember srt:MinimumMember 2019-07-01 2019-09-30 0000817720 us-gaap:RevolvingCreditFacilityMember syna:AmendmentAndRestatementAgreementMember us-gaap:LondonInterbankOfferedRateLIBORMember srt:MaximumMember 2019-07-01 2019-09-30 0000817720 us-gaap:RevolvingCreditFacilityMember syna:AmendmentAndRestatementAgreementMember srt:MinimumMember 2019-07-01 2019-09-30 0000817720 us-gaap:RevolvingCreditFacilityMember syna:AmendmentAndRestatementAgreementMember srt:MaximumMember 2019-07-01 2019-09-30 0000817720 syna:ForFourFiscalQuartersEndingAfterDateOfMaterialAcquisitionMember syna:AmendmentAndRestatementAgreementMember us-gaap:RevolvingCreditFacilityMember 2019-09-30 0000817720 syna:ThereafterMember syna:AmendmentAndRestatementAgreementMember us-gaap:RevolvingCreditFacilityMember 2019-09-30 0000817720 us-gaap:ResearchAndDevelopmentExpenseMember 2019-07-01 2019-09-30 0000817720 us-gaap:ResearchAndDevelopmentExpenseMember 2018-07-01 2018-09-30 0000817720 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0000817720 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0000817720 us-gaap:EmployeeStockOptionMember 2019-09-27 0000817720 syna:DeferredStockUnitsMember 2019-06-30 0000817720 syna:DeferredStockUnitsMember 2019-09-30 0000817720 syna:DeferredStockUnitsMember 2019-09-27 0000817720 syna:MarketStockUnitsMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-07-01 2019-09-30 0000817720 syna:MarketStockUnitsMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2019-07-01 2019-09-30 0000817720 syna:MarketStockUnitsMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2019-07-01 2019-09-30 0000817720 syna:MarketStockUnitsMember syna:ShareBasedCompensationAwardTrancheFourMember 2019-07-01 2019-09-30 0000817720 syna:MarketStockUnitsMember srt:MinimumMember 2019-07-01 2019-09-30 0000817720 syna:MarketStockUnitsMember srt:MaximumMember 2019-07-01 2019-09-30 0000817720 srt:MaximumMember us-gaap:ShareBasedCompensationAwardTrancheOneMember syna:ThreeYearPerformanceMember syna:MarketStockUnitsMember 2019-07-01 2019-09-30 0000817720 srt:MaximumMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember syna:ThreeYearPerformanceMember syna:MarketStockUnitsMember 2019-07-01 2019-09-30 0000817720 srt:MaximumMember us-gaap:ShareBasedCompensationAwardTrancheOneMember syna:FourYearPerformanceMember syna:MarketStockUnitsMember 2019-07-01 2019-09-30 0000817720 srt:MaximumMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember syna:FourYearPerformanceMember syna:MarketStockUnitsMember 2019-07-01 2019-09-30 0000817720 srt:MaximumMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember syna:FourYearPerformanceMember syna:MarketStockUnitsMember 2019-07-01 2019-09-30 0000817720 syna:MarketStockUnitsMember 2019-06-30 0000817720 syna:MarketStockUnitsMember 2019-09-30 0000817720 syna:MarketStockUnitsMember 2019-09-27 0000817720 srt:MinimumMember syna:PerformanceStockUnitsMember 2019-07-01 2019-09-30 0000817720 srt:MaximumMember syna:PerformanceStockUnitsMember 2019-07-01 2019-09-30 0000817720 syna:PerformanceStockUnitsMember 2019-06-30 0000817720 syna:PerformanceStockUnitsMember 2019-09-30 0000817720 syna:PerformanceStockUnitsMember 2019-09-27 0000817720 syna:EmployeeStockPurchasePlanMember 2019-07-01 2019-09-30 0000817720 2018-07-01 2019-06-30 syna:Segment syna:Product 0000817720 country:CN 2019-07-01 2019-09-30 0000817720 country:CN 2018-07-01 2018-09-30 0000817720 country:TW 2019-07-01 2019-09-30 0000817720 country:TW 2018-07-01 2018-09-30 0000817720 country:JP 2019-07-01 2019-09-30 0000817720 country:JP 2018-07-01 2018-09-30 0000817720 syna:OtherForeignCountryMember 2019-07-01 2019-09-30 0000817720 syna:OtherForeignCountryMember 2018-07-01 2018-09-30 0000817720 country:KR 2019-07-01 2019-09-30 0000817720 country:KR 2018-07-01 2018-09-30 0000817720 country:US 2019-07-01 2019-09-30 0000817720 country:US 2018-07-01 2018-09-30 0000817720 syna:MobileProductApplicationsMember 2019-07-01 2019-09-30 0000817720 syna:MobileProductApplicationsMember 2018-07-01 2018-09-30 0000817720 syna:PcProductApplicationsMember 2019-07-01 2019-09-30 0000817720 syna:PcProductApplicationsMember 2018-07-01 2018-09-30 0000817720 syna:InternetOfThingsProductApplicationsMember 2019-07-01 2019-09-30 0000817720 syna:InternetOfThingsProductApplicationsMember 2018-07-01 2018-09-30 0000817720 us-gaap:SalesRevenueNetMember syna:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000817720 us-gaap:SalesRevenueNetMember syna:CustomerAMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000817720 us-gaap:SalesRevenueNetMember syna:CustomerBMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000817720 us-gaap:SalesRevenueNetMember syna:CustomerCMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000817720 srt:MaximumMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000817720 srt:MaximumMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2018-09-30 0000817720 syna:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2019-07-01 2019-09-30 0000817720 syna:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2018-07-01 2019-06-30 0000817720 syna:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2019-07-01 2019-09-30 0000817720 syna:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2019-07-01 2019-09-30 0000817720 syna:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2018-07-01 2019-06-30 0000817720 srt:MaximumMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0000817720 srt:MaximumMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2018-07-01 2019-06-30 0000817720 syna:EmployeeSeveranceAndBenefitsMember syna:TwoThousandNineteenRestructuringPlanMember 2018-07-01 2019-06-30 0000817720 syna:EmployeeSeveranceAndBenefitsMember syna:TwoThousandNineteenRestructuringPlanMember 2019-06-30 0000817720 syna:EmployeeSeveranceAndBenefitsMember syna:TwoThousandNineteenRestructuringPlanMember 2019-07-01 2019-09-30 0000817720 syna:EmployeeSeveranceAndBenefitsMember syna:TwoThousandNineteenRestructuringPlanMember 2019-09-30

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 28, 2019

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             .

Commission file number 000-49602

 

SYNAPTICS INCORPORATED

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

77-0118518

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

1251 McKay Drive

San Jose, California 95131

(Address of principal executive offices) (Zip code)

(408) 904-1100

(Registrant’s telephone number, including area code)

 

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, par value $.001 per share

SYNA

The NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

  

Accelerated filer

 

 

 

 

 

Non-accelerated filer

 

  

  

Smaller reporting company

 

Emerging growth company

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

Number of shares of Common Stock outstanding at November 1, 2019: 33,464,178

 

 


SYNAPTICS INCORPORATED

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 28, 2019

TABLE OF CONTENTS

 

 

 

 

  

 

  

Page

Part I. Financial Information

  

 

 

 

 

 

   

 

Item 1.

   

Condensed Consolidated Financial Statements (Unaudited):

  

3

 

 

 

 

 

 

 

  

Condensed Consolidated Balance Sheets—September 30, 2019 and June 30, 2019

  

3

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Income—Three Months Ended September 30, 2019 and 2018

 

4

 

 

 

 

 

 

 

  

Condensed Consolidated Statements of Comprehensive Income—Three Months Ended September 30, 2019 and 2018

  

5

 

 

 

 

 

 

 

 

Condensed Consolidated Statements of Stockholders’ Equity

 

6

 

 

 

 

 

 

 

 

 

 

  

Condensed Consolidated Statements of Cash Flows—Three Months Ended September 30, 2019 and 2018

  

7

 

 

 

 

 

 

 

  

Notes to Condensed Consolidated Financial Statements

  

8

 

 

 

 

 

 

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

22

 

 

 

 

 

 

Item 3.

  

Quantitative and Qualitative Disclosures About Market Risk

  

29

 

 

 

 

 

 

Item 4.

  

Controls and Procedures

  

29

 

 

Part II. Other Information

  

 

 

 

 

 

 

 

Item 1.

 

Legal Proceedings

 

30

 

 

 

 

 

 

 

 

 

Item 1A.

 

Risk Factors

 

30

 

 

 

 

 

 

 

 

 

Item 2.

  

Unregistered Sales of Equity Securities and Use of Proceeds

  

30

 

 

 

 

 

 

Item 6.

  

Exhibits

  

31

 

 

 

 

 

 

 

Signatures

  

32

 

 

 


PART I—FINANCIAL INFORMATION

 

 

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

SYNAPTICS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(in millions, except par value and share amounts)

(unaudited)

 

 

 

September 30,

 

 

June 30,

 

 

 

2019

 

 

2019

 

ASSETS

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

350.8

 

 

$

327.8

 

Accounts receivable, net of allowances of $2.1 at September 30,  and

   June 30, 2019

 

 

232.2

 

 

 

230.0

 

Inventories

 

 

138.2

 

 

 

158.7

 

Prepaid expenses and other current assets

 

 

15.9

 

 

 

14.6

 

Total current assets

 

 

737.1

 

 

 

731.1

 

Property and equipment at cost, net of accumulated depreciation of $140.0

   and $133.1 at September 30, 2019 and June 30, 2019, respectively

 

 

98.8

 

 

 

103.0

 

Goodwill

 

 

372.8

 

 

 

372.8

 

Acquired intangibles, net

 

 

126.6

 

 

 

144.8

 

Non-current other assets

 

 

89.0

 

 

 

58.1

 

 

 

$

1,424.3

 

 

$

1,409.8

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

99.0

 

 

$

98.3

 

Accrued compensation

 

 

31.3

 

 

 

30.4

 

Income taxes payable

 

 

9.5

 

 

 

19.1

 

Other accrued liabilities

 

 

107.7

 

 

 

106.1

 

Total current liabilities

 

 

247.5

 

 

 

253.9

 

Convertible notes, net

 

 

472.8

 

 

 

468.3

 

Other long-term liabilities

 

 

49.2

 

 

 

30.3

 

Total liabilities

 

 

769.5

 

 

 

752.5

 

Stockholders' Equity:

 

 

 

 

 

 

 

 

Common stock:

 

 

 

 

 

 

 

 

$0.001 par value; 120,000,000 shares authorized,

   64,493,058 and 64,283,948 shares issued, and 33,003,182 and 33,349,735 shares

   outstanding, at September 30, 2019 and June 30, 2019, respectively

 

 

0.1

 

 

 

0.1

 

Additional paid-in capital

 

 

1,277.5

 

 

 

1,266.1

 

Treasury stock: 31,489,876 and 30,934,213 common treasury shares at

   September 30, 2019 and June 30, 2019, respectively, at cost

 

 

(1,209.4

)

 

 

(1,192.4

)

Retained earnings

 

 

586.6

 

 

 

583.5

 

Total stockholders' equity

 

 

654.8

 

 

 

657.3

 

 

 

$

1,424.3

 

 

$

1,409.8

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

 

3

 


 

SYNAPTICS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in millions, except per share data)

(unaudited)

 

 

 

Three Months Ended

 

 

 

September 30,

 

 

 

2019

 

 

2018

 

Net revenue

 

$

339.9

 

 

$

417.6

 

Cost of revenue

 

 

213.7

 

 

 

276.7

 

Gross margin

 

 

126.2

 

 

 

140.9

 

Operating expenses:

 

 

 

 

 

 

 

 

Research and development

 

 

86.0

 

 

 

90.0

 

Selling, general, and administrative

 

 

27.5

 

 

 

33.9

 

Acquired intangibles amortization

 

 

2.9

 

 

 

2.9

 

Restructuring costs

 

 

6.6

 

 

 

8.3

 

Total operating expenses

 

 

123.0

 

 

 

135.1

 

Operating income

 

 

3.2

 

 

 

5.8

 

Interest and other expense, net

 

 

(3.6

)

 

 

(1.9

)

Income/(loss) before provision/(benefit) for income taxes and

   equity investment loss

 

 

(0.4

)

 

 

3.9

 

Provision/(benefit) for income taxes

 

 

(4.9

)

 

 

(0.3

)

Equity investment loss

 

 

(0.5

)

 

 

(0.4

)

Net income

 

$

4.0

 

 

$

3.8

 

Net income per share:

 

 

 

 

 

 

 

 

Basic

 

$

0.12

 

 

$

0.11

 

Diluted

 

$

0.12

 

 

$

0.11

 

Shares used in computing net income per share:

 

 

 

 

 

 

 

 

Basic

 

 

33.0

 

 

 

35.1

 

Diluted

 

 

33.6

 

 

 

36.1

 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

 

4

 


 

SYNAPTICS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in millions)

(unaudited)

 

 

 

Three Months Ended

 

 

 

September 30,

 

 

 

2019

 

 

2018

 

Net income

 

$

4.0

 

 

$

3.8

 

Other comprehensive income:

 

 

 

 

 

 

 

 

Change in unrealized net gain on investment

 

 

 

 

 

(1.5

)

Comprehensive income

 

$

4.0

 

 

$

2.3

 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

 

5

 


 

SYNAPTICS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in millions, except share amounts)

(unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Common Stock

 

 

Paid-in

 

 

Treasury

 

 

Retained

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Earnings

 

 

Equity

 

Balance at June 30, 2019, as reported

 

 

64,283,948

 

 

$

0.1

 

 

$

1,266.1

 

 

$

(1,192.4

)

 

$

583.5

 

 

$

657.3

 

Cumulative effect of changes in accounting

   principles

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(0.9

)

 

$

(0.9

)

Balance at June 30, 2019, as adjusted

 

 

64,283,948

 

 

 

0.1

 

 

 

1,266.1

 

 

 

(1,192.4

)

 

 

582.6

 

 

 

656.4

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4.0

 

 

 

4.0

 

Issuance of common stock for share-

   based award compensation plans

 

 

209,110

 

 

 

 

 

 

1.7

 

 

 

 

 

 

 

 

 

1.7

 

Payroll taxes for deferred stock units

 

 

 

 

 

 

 

 

(1.5

)

 

 

 

 

 

 

 

 

(1.5

)

Purchases of treasury stock

 

 

 

 

 

 

 

 

 

 

 

(17.0

)

 

 

 

 

 

(17.0

)

Share-based compensation

 

 

 

 

 

 

 

 

11.2

 

 

 

 

 

 

 

 

 

11.2

 

Balance at September 30, 2019

 

 

64,493,058

 

 

$

0.1

 

 

$

1,277.5

 

 

$

(1,209.4

)

 

$

586.6

 

 

$

654.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Other

 

 

 

 

 

 

Total

 

 

 

Common Stock

 

 

Paid-in

 

 

Treasury

 

 

Comprehensive

 

 

Retained

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Stock

 

 

Income

 

 

Earnings

 

 

Equity

 

Balance at June 30, 2018

 

 

62,889,679

 

 

$

0.1

 

 

$

1,195.2

 

 

$

(1,073.9

)

 

$

1.5

 

 

$

606.4

 

 

$

729.3

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.8

 

 

 

3.8

 

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1.5

)

 

 

 

 

 

(1.5

)

Issuance of common stock for share-

   based award compensation plans

 

 

140,379

 

 

 

 

 

 

2.1

 

 

 

 

 

 

 

 

 

 

 

 

2.1

 

Payroll taxes for deferred stock units

 

 

 

 

 

 

 

 

(0.9

)

 

 

 

 

 

 

 

 

 

 

 

(0.9

)

Purchases of treasury stock

 

 

 

 

 

 

 

 

 

 

 

(39.4

)

 

 

 

 

 

 

 

 

(39.4

)

Share-based compensation

 

 

 

 

 

 

 

 

16.7

 

 

 

 

 

 

 

 

 

 

 

 

16.7

 

Balance at September 30, 2018

 

 

63,030,058

 

 

$

0.1

 

 

$

1,213.1

 

 

$

(1,113.3

)

 

$

 

 

$

610.2

 

 

$

710.1

 

 

See accompanying notes to condensed consolidated financial statements (unaudited).

 

 

6

 


 

SYNAPTICS INCORPORATED AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(unaudited)

 

 

 

Three Months Ended

 

 

 

September 30,

 

 

 

2019

 

 

2018

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

Net income

 

$

4.0

 

 

$

3.8

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Share-based compensation costs

 

 

11.2

 

 

 

16.7

 

Depreciation and amortization

 

 

7.2

 

 

 

10.0

 

Acquired intangibles amortization

 

 

18.2

 

 

 

20.0

 

Deferred taxes

 

 

(2.4

)

 

 

(5.6

)

Amortization of convertible debt discount and issuance costs

 

 

4.5

 

 

 

4.4

 

Amortization of debt issuance costs

 

 

0.1

 

 

 

0.1

 

Impairment recovery on investments

 

 

 

 

 

(2.8

)

Acquired in-process research and development

 

 

3.7

 

 

 

 

Arbitration settlement

 

 

 

 

 

(1.9

)

Equity investment loss

 

 

0.5

 

 

 

0.4

 

Foreign currency remeasurement loss

 

 

 

 

 

0.1

 

Changes in operating assets and liabilities, net of acquisitions:

 

 

 

 

 

 

 

 

Accounts receivable, net

 

 

(2.2

)

 

 

(38.3

)

Inventories

 

 

20.5

 

 

 

(30.0

)

Prepaid expenses and other current assets

 

 

(1.9

)

 

 

(13.8

)

Other assets

 

 

(1.0

)

 

 

1.1

 

Accounts payable

 

 

2.6

 

 

 

22.3

 

Accrued compensation

 

 

0.9

 

 

 

(1.6

)

Income taxes payable

 

 

(9.4

)

 

 

3.7

 

Other accrued liabilities

 

 

(9.2

)

 

 

16.0

 

Net cash provided by operating activities

 

 

47.3

 

 

 

4.6

 

Cash flows from investing activities

 

 

 

 

 

 

 

 

Purchase of in-process research and development

 

 

(2.5

)

 

 

 

Proceeds from sales of investments

 

 

 

 

 

2.8

 

Purchases of property and equipment

 

 

(5.0

)

 

 

(6.8

)

Net cash used in investing activities

 

 

(7.5

)

 

 

(4.0

)

Cash flows from financing activities

 

 

 

 

 

 

 

 

Purchases of treasury stock

 

 

(17.0

)

 

 

(39.4

)

Proceeds from issuance of shares

 

 

1.7

 

 

 

2.1

 

Payroll taxes for deferred stock and market stock units

 

 

(1.5

)

 

 

(0.9

)

Net cash used in financing activities

 

 

(16.8

)

 

 

(38.2

)

Effect of exchange rate changes on cash and cash equivalents

 

 

 

 

 

(0.1

)

Net increase/(decrease) in cash and cash equivalents

 

 

23.0

 

 

 

(37.7

)

Cash and cash equivalents at beginning of period

 

 

327.8

 

 

 

301.0

 

Cash and cash equivalents at end of period

 

$

350.8

 

 

$

263.3

 

 

 

 

 

 

 

 

 

 

Supplemental disclosures of cash flow information

 

 

 

 

 

 

 

 

Cash paid for taxes

 

$

7.1

 

 

$

1.7

 

Non-cash investing and financing activities:

 

 

 

 

 

 

 

 

Purchases of property and equipment in current liabilities

 

$

1.9

 

 

$

2.9

 

 

See accompanying notes to condensed consolidated financial statements (unaudited)

 

 

7

 


 

SYNAPTICS INCORPORATED AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

 

1. Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, and U.S. generally accepted accounting principles, or U.S. GAAP. Certain information or footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to SEC rules and regulations. In our opinion, the financial statements include all adjustments, which are of a normal and recurring nature and necessary for the fair presentation of the results of the interim periods presented. The results of operations for the interim periods are not necessarily indicative of the operating results for the full fiscal year or any future period. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended June 29, 2019.

The consolidated financial statements include our financial statements and those of our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.

Our fiscal year is the 52- or 53-week period ending on the last Saturday in June. Our fiscal 2020 is a 52-week period ending June 27, 2020, and our fiscal 2019 was a 52-week period ending on June 29, 2019. The fiscal periods presented in this report are 13-weeks for the three months ended September 28, 2019, and September 29, 2018. For simplicity, the accompanying condensed consolidated financial statements have been shown as ending on calendar quarter end dates as of and for all periods presented, unless otherwise indicated.

Effective at the beginning of our first quarter of fiscal 2020, the quarter ended September 30, 2019, we adopted the requirements of Accounting Standards Update, or ASU, 2016-02, Leases, or Topic 842, issued by the Financial Accounting Standards Board, or FASB.

Use of Estimates

The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, allowance for doubtful accounts, cost of revenue, inventories, loss on purchase commitments, product warranty, accrued liabilities, share-based compensation costs, provision for income taxes, deferred income tax asset valuation allowances, uncertain tax positions, goodwill, intangible assets, investments and loss contingencies. We base our estimates on historical experience, applicable laws and regulations, and various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Foreign Currency Transactions and Foreign Exchange Contracts

The U.S. dollar is our functional and reporting currency.  We remeasure our monetary assets and liabilities not denominated in the functional currency into U.S. dollar equivalents at the rate of exchange in effect on the balance sheet date. We measure and record non-monetary balance sheet accounts at the historical rate in effect at the date of transaction. We remeasure foreign currency expenses at the weighted average exchange rate in the month that the transaction occurred. Our foreign currency transactions and remeasurement gains and losses are included in selling, general, and administrative expenses in the condensed consolidated statements of income and resulted in net gains of $0.4 million in the three months ended September 30, 2019 and net losses of $0.4 million for the three months ended September 30, 2018.

8

 


 

Leases

We determine if a contract is a lease or contains a lease at the inception of the contract and reassess that conclusion if the contract is modified. All leases are assessed for classification as an operating lease or a finance lease. Operating lease right-of-use, or ROU, assets are included in non-current other assets on our condensed consolidated balance sheet. Operating lease liabilities are separated into a current portion, included within accrued liabilities on our condensed consolidated balance sheet, and a non-current portion, included within operating lease liabilities on our condensed consolidated balance sheet. We do not have any finance lease ROU assets or liabilities. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. We do not obtain and control the right to use the identified asset until the lease commencement date.

Our lease liabilities are recognized at the applicable lease commencement date based on the present value of the lease payments required to be paid over the lease term. Because the interest rate implicit in the lease is not readily determinable, we generally use our incremental borrowing rate to discount the lease payments to present value. The estimated incremental borrowing rate is derived from information available at the lease commencement date. We factor in publicly available data for instruments with similar characteristics when calculating our incremental borrowing rates. Our ROU assets are also recognized at the applicable lease commencement date. The ROU asset equals the carrying amount of the related lease liability, adjusted for any lease payments made prior to lease commencement and lease incentives provided by the lessor. Variable lease payments are expensed as incurred and do not factor into the measurement of the applicable ROU asset or lease liability.

The term of our leases equals the non-cancellable period of the lease, including any rent-free periods provided by the lessor, and also include options to renew or extend the lease (including by not terminating the lease) that we are reasonably certain to exercise. We establish the term of each lease at lease commencement and reassess that term in subsequent periods when one of the triggering events outlined in Topic 842 occurs. Operating lease cost for lease payments is recognized on a straight-line basis over the lease term.

Our lease contracts often include lease and non-lease components. For our leases, we have elected the practical expedient offered by the standard to not separate lease from non-lease components and account for them as a single lease component.

We have elected, for all classes of underlying assets, not to recognize ROU assets and lease liabilities for leases with a term of twelve months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.

Asset Acquisition

We acquired an emerging technology startup company focused on the design of high-speed connectivity products in August 2019. The purchase price primarily included $2.5 million in cash paid at the closing, and up to $6.5 million in contingent consideration which is payable in set amounts upon meeting various milestones on dates from December 2021 through December 2023. As of September 30, 2019, we have accrued $1.3 million of the contingent consideration as that is the portion which is currently estimable and probable. The acquisition was accounted for as an asset purchase and accordingly we expensed $3.7 million of in-process research and development, recorded liabilities of approximately $1.5 million and recorded a long-term deferred tax asset of $0.3 million in the three months ended September 30, 2019.

2. Impact of Recently Adopted Accounting Pronouncements

On June 30, 2019, we adopted Accounting Standards Codification Topic 842, or ASC 842, Leases, which requires recognition of ROU assets and lease liabilities for most leases on our consolidated balance sheet. We adopted ASC 842 using a modified retrospective transition approach as of the effective date as permitted by ASC 842. As a result, we were not required to adjust our comparative period financial information for effects of the standard or make the new required lease disclosures for the periods before the date of adoption. We elected the package of practical expedients which allows us not to reassess (1) whether existing or expired contracts, as of the adoption date, contain leases, (2) the lease classification for existing leases, and (3) whether existing initial direct costs meet the new definition. We also elected the practical expedient to not separate lease and non-lease components for our leases, and to not recognize ROU assets and liabilities for short-term leases

The standard had a material impact on our condensed consolidated balance sheet but did not have a significant impact on our condensed consolidated statements of income or cash flows. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases.

The adoption of this new standard at June 30, 2019, resulted in the following changes:

 

assets increased by $27.8 million, primarily representing the recognition of ROU assets for operating leases; and

 

liabilities increased by $28.4 million, primarily representing the recognition of lease liabilities for operating leases.

9

 


 

3. Revenue Recognition

We adopted Accounting Standards Codification Topic 606, or ASC 606, Revenue from Contracts with Customers, at the beginning of our fiscal 2019. Our revenue is primarily generated from the sale of application specific integrated circuit chips, or ASIC chips, either directly to a customer or to a distributor. Revenues are recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to receive in exchange for those goods or services. All of our revenue, except an inconsequential amount, is recognized at a point in time, either on shipment or delivery of the product, depending on customer terms and conditions. We generally warrant our products for a period of 12 months from the date of sale and estimate probable product warranty costs at the time we recognize revenue as the warranty is considered an assurance warranty and not a performance obligation. Non-product revenue is recognized over the same period of time such performance obligations are satisfied. We then select an appropriate method for measuring satisfaction of the performance obligations.

Revenue from sales to distributors is recognized upon shipment of the product to the distributors (sell-in basis). Master sales agreements are in place with certain customers, and these agreements typically contain terms and conditions with respect to payment, delivery, warranty and supply. In the absence of a master sales agreement, we consider a customer's purchase order or our standard terms and conditions to be the contract with the customer.

Our pricing terms are negotiated independently, on a stand-alone basis. In determining the transaction price, we evaluate whether the price is subject to refund or adjustment to determine the net consideration which we expect to receive for the sale of such products. In limited situations, we make sales to certain customers under arrangements where we grant stock rotation rights, price protection and price allowances; variable consideration associated with these rights is expected to be inconsequential. These adjustments and incentives are accounted for as variable consideration, classified as other current liabilities under the revenue standard and are shown as customer obligations in Note 9 Other Accrued Liabilities and Other Long-Term Liabilities. We estimate the amount of variable consideration for such arrangements based on the expected value to be provided to customers, and we do not believe that there will be significant changes to our estimates of variable consideration. When incentives, stock rotation rights, price protection, volume discounts, or price allowances are applicable, they are estimated and recorded in the period the related revenue is recognized. Stock rotation reserves are based on historical return rates and recorded as a reduction to revenue with a corresponding reduction to cost of goods sold for the estimated cost of inventory that is expected to be returned and recorded as prepaid expenses and other current assets. In limited circumstances, we enter into volume-based tiered pricing arrangements and we estimate total unit volumes under such arrangement to determine the expected transaction price for the units expected to be transferred. Such arrangements are accounted for as contract liabilities within other accrued liabilities. Sales returns liabilities are recorded as refund liabilities within other accrued liabilities.

Our accounts receivable balance is from contracts with customers and represents our unconditional right to receive consideration from customers. Payments are generally due within three months upon completion of the performance obligation and subsequent invoicing and therefore, do not include significant financing components. To date, there have been no material impairment losses on accounts receivable. There was $1.0 million in contract assets recorded on the condensed consolidated balance sheets as of September 30, 2019 and $0.9 million as of June 30, 2019. Contract assets are presented as part of prepaid expenses and other current assets. Contract liabilities and refund liabilities were $6.4 million and $38.3 million, respectively, as of September 30, 2019, and $4.5 million and $47.5 million, respectively, as of June 30, 2019. Both contract liabilities and refund liabilities are presented as part of customer obligations in Note 9 Other Accrued Liabilities and Other Long-Term Liabilities. During the three months ended September 30, 2019 and the three months ended September 30, 2018, we recognized $0.2 million and $0.4 million, respectively, in revenue related to contract liabilities outstanding as of the beginning of each such fiscal year.

We invoice customers for each delivery upon shipment and recognize revenue in accordance with delivery terms. As of September 30, 2019, we did not have any remaining unsatisfied performance obligations with an original duration greater than one year. Accordingly, under the optional exception provided by ASC 606, we do not disclose revenues allocated to future performance obligations of partially completed contracts. We have elected to account for shipping and handling costs as fulfillment costs before the customer obtains control of the goods. We continue to classify shipping and handling costs as a cost of revenue. We have elected to continue to account for collection of all taxes on a net basis.  

We incur commission expense that is incremental to obtaining contracts with customers. Sales commissions (which are recorded as a selling, general and administrative expense in the condensed consolidated statements of income) are expensed when the product is shipped because such commissions are owed after shipment.

Revenue from contracts with customers disaggregated by geographic area based on customer location and groups of similar products is presented in Note 14 Segment, Customers, and Geographical Information.

 

 

10

 


 

4. Net Income Per Share

The computation of basic and diluted net income per share was as follows (in millions, except per share data):

 

 

 

Three Months Ended

 

 

 

September 30,

 

 

 

2019

 

 

2018

 

Numerator:

 

 

 

 

 

 

 

 

Net income

 

$

4.0

 

 

$

3.8

 

Denominator:

 

 

 

 

 

 

 

 

Shares, basic

 

 

33.0

 

 

 

35.1

 

Effect of dilutive share-based awards

 

 

0.6

 

 

 

1.0

 

Shares, diluted

 

 

33.6

 

 

 

36.1

 

Net income per share:

 

 

 

 

 

 

 

 

Basic

 

$

0.12

 

 

$

0.11

 

Diluted

 

$

0.12

 

 

$

0.11

 

Our basic net income per share amounts for each period presented have been computed using the weighted average number of shares of common stock outstanding over the period measured. Our diluted net income per share amounts for each period presented include the weighted average effect of potentially dilutive shares. We use the treasury stock method to determine the dilutive effect of our stock options, deferred stock units, or DSUs, market stock units, or MSUs, performance stock units, or PSUs, and our convertible notes.

Dilutive net income per share amounts do not include the potential weighted average effect of 1,340,521 and 1,357,565 shares of common stock related to certain share-based awards that were outstanding during the three months ended September 30, 2019 and 2018, respectively.  These share-based awards were not included in the computation of diluted net income per share because their effect would have been antidilutive.

 

 

5. Fair Value

Our financial assets, measured at fair value on a recurring basis under the fair value hierarchy, consisted of money market funds within level 1 financial assets and totaled $331.0 million and $313.7 million as of September 30, 2019 and June 30, 2019, respectively. These money market funds were included in cash and cash equivalents in our condensed consolidated balance sheets.

The fair values of our accounts receivable and accounts payable approximate their carrying values because of the short-term nature of those instruments. Intangible assets, property and equipment, and goodwill are measured at fair value on a non-recurring basis if impairment is indicated.

 

 

6. Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value and consisted of the following (in millions):

 

 

 

September 30,

 

 

June 30,

 

 

 

2019

 

 

2019

 

Raw materials and work-in-progress

 

$

72.1

 

 

$

110.7

 

Finished goods

 

 

66.1

 

 

 

48.0

 

 

 

$

138.2

 

 

$

158.7

 

 

We record a write-down, if necessary, to reduce the carrying value of inventory to its net realizable value. The effect of these write-downs is to establish a new cost basis in the related inventory, which we do not subsequently write up. We also record a liability and charge to cost of revenue for estimated losses on inventory we are obligated to purchase from our contract manufacturers when such losses become probable from customer delays, order cancellations, or other factors.  

 

 

11

 


 

7. Acquired Intangibles and Goodwill

Acquired Intangibles

The following table summarizes the life, the gross carrying value and the related accumulated amortization of our acquired intangible assets as of September 30, 2019 and June 30, 2019 (in millions):

 

 

 

 

 

 

 

September 30, 2019

 

 

June 30, 2019

 

 

 

Weighted Average

Life in Years

 

 

Gross Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Carrying

Value

 

 

Gross Carrying

Value

 

 

Accumulated

Amortization

 

 

Net Carrying

Value

 

Display driver technology

 

 

5.3

 

 

$

164.0

 

 

$

(155.9

)

 

$

8.1

 

 

$

164.0

 

 

$

(148.1

)

 

$

15.9

 

Audio and video

   technology

 

 

5.3

 

 

 

138.6

 

 

 

(56.1

)

 

 

82.5

 

 

 

138.6

 

 

 

(49.4

)

 

 

89.2

 

Customer relationships

 

 

4.1

 

 

 

81.8

 

 

 

(52.8

)

 

 

29.0

 

 

 

81.8

 

 

 

(49.9

)